mk-3475
Showing 1 - 19 of 19
Bladder Cancer Trial in Japan (drug, procedure, radiation)
Not yet recruiting
- Bladder Cancer
- MK-3475
- +3 more
-
Kobe, Hyogo, Japan
- +3 more
May 26, 2023
Colorectal Cancer Trial in Baltimore (Oral CC-486, Romidepsin, MK-3475)
Completed
- Colorectal Cancer
- Oral CC-486
- +2 more
-
Baltimore, MarylandJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 21, 2022
Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)
Not yet recruiting
- Untreated Advanced or Recurrent Thymic Carcinomas
- MK-3475
- +3 more
-
Chuo, Tokyo, JapanNational Cancer Center Hospital
Apr 16, 2023
NSCLC Trial in Portland (MK-3475, Gemcitabine)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- MK-3475
- Gemcitabine
-
Portland, Oregon
- +1 more
Jan 31, 2022
Melanoma, Lung Cancer Trial in New Haven (MK-3475, Stereotactic Body Radiation Therapy (SBRT))
Suspended
- Melanoma
- Lung Cancer
- MK-3475
- Stereotactic Body Radiation Therapy (SBRT)
-
New Haven, ConnecticutYale Cancer Center
Oct 5, 2021
Brain Cancer Trial in United States (MK-3475)
Completed
- Brain Cancer
- MK-3475
-
Los Angeles, California
- +6 more
Jun 6, 2022
Melanoma Trial in Pittsburgh (MK-3475, Peginterferon alfa-2b)
Completed
- Melanoma
- MK-3475
- Peginterferon alfa-2b
-
Pittsburgh, PennsylvaniaHillman Cancer Center
May 3, 2021
Melanoma, NSCLC, Brain Metastases Trial in New Haven (MK-3475)
Completed
- Melanoma
- +2 more
- MK-3475
-
New Haven, ConnecticutSmilow Cancer Center at Yale New Haven Hospital
Mar 22, 2021
NSCLC Trial in United States (MK-3475, Carboplatin, Paclitaxel)
Active, not recruiting
- Non-Small Cell Lung Cancer
- MK-3475
- +3 more
-
La Jolla, California
- +14 more
Oct 1, 2021
NSCLC Trial in Mexico city (MK-3475, Docetaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- MK-3475
- Docetaxel
-
Mexico city, Distrito Federal, MexicoNational Cancer Institute of Mexico
Dec 14, 2020
Recurrent Head Neck Cancer, Carcinoma, Squamous Cell of Head and Neck Trial in Baltimore, Philadelphia, Pittsburgh
Recruiting
- Recurrent Head and Neck Cancer
- Carcinoma, Squamous Cell of Head and Neck
- Reirradiation
- MK-3475
-
Baltimore, Maryland
- +3 more
Mar 25, 2022
Endometrial Cancer, Endometrial Carcinoma, Tumors, Endometrial Trial in Saint Louis (drug, procedure, radiation)
Completed
- Endometrial Cancer
- +2 more
- MK-3475
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 6, 2020
NSCLC Trial in United States (Imprime PGG, MK-3475)
Active, not recruiting
- Non-Small Cell Lung Cancer
- Imprime PGG
- MK-3475
-
Chicago, Illinois
- +4 more
Oct 6, 2022
Clear Cell Renal Carcinoma Trial in United States (MK-3475, Bevacizumab)
Multiple Myeloma Trial in Baltimore (MK-3475, Pomalidomide, Dexamethasone)
Terminated
- Multiple Myeloma
- MK-3475
- +2 more
-
Baltimore, MarylandGreenebaum Cancer Center at University of Maryland Medical Cente
Nov 1, 2019
Advanced GI Cancer Trial in Salt Lake City (MK-3475)
Terminated
- Advanced GI Cancer
- MK-3475
-
Salt Lake City, UtahHuntsman Cancer Institute
Nov 8, 2018
Multiple Myeloma Trial in Ann Arbor, Milwaukee (Autologous Stem Cell Transplant, Melphalan, Lenalidomide)
Completed
- Multiple Myeloma
- Autologous Stem Cell Transplant
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jul 2, 2018
Breast Tumors, Bone Tumors Trial in Melbourne (Stereotactic Ablative Body Radiosurgery (SABR), MK-3475)
Completed
- Breast Neoplasms
- Bone Neoplasms
- Stereotactic Ablative Body Radiosurgery (SABR)
- MK-3475
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Oct 17, 2017